 |
|
|
| |
B/F/TAF vs DTG/ABC/3TC or DTG + F/TAF in Treatment-Naïve Adults With High Baseline Viral Load or Low Baseline CD4 Count in 2 Phase 3 Randomized, Controlled Clinical Trials
|
| |
| |
Reported by Jules Levin
22nd International AIDS Conference, 23-25 July 2018, Amsterdam, Netherlands
Daniel Podzamczer,1 Hans-JUrgen Stellbrink,2 Chloe Orkin,3 Anton Pozniak,4
Jose Arribas,5 Ellen Koenig,6 Moti Ramgopal,7 Axel Baumgarten,8 Xuelian Wei,9 Andrew Cheng,9 Devi SenGupta,9 Hal Martin,9 Erin Quirk9
1Hospital Universitari de Bellvitge, Barcelona, Spain; 2ICH Study Center, Hamburg, Germany; 3Barts Health NHT Trust, Royal London Hospital, Ambrose King Centre, London, UK; 4Chelsea & Westminster Hospital, London, UK; 5Hospital Universitario La Paz, Madrid, Spain; 6Instituto Dominicano de Estudios
Virologicos IDEV, Santo Domingo, DM; 7Midway Immunology and Research Center, Fort Pierce, Florida, USA; 8Zibp Zentrum fUr Infektiologie Berlin Prenzlauer Berg, Berlin, Germany; 9Gilead Sciences, Inc.,
Foster City, California, USA
|
| |
|
|
|
|
|
